Emodin-6-O-β-d-glucoside inhibits high-glucose-induced vascular inflammation

Inflammation

Volumn 37, Issue 2, 2014, Pages 306-313

  Lee, Wonhwa ^a,b   Ku, Sae Kwang ^c   Lee, Doohyun ^a   Lee, Taeho ^a   Bae, Jong Sup ^a  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c Daegu Haany University   (South Korea)

Author keywords

atherosclerosis; emodin 6 O d glucoside; high glucose; HUVEC; inflammation

Indexed keywords

ANTIINFLAMMATORY AGENT; EMODIN 6 O BETA DEXTRO GLUCOSIDE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL PERMEABILITY; CELL ADHESION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; ENZYME ACTIVATION; GLUCOSE INTAKE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MONOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VASCULITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CAPILLARY PERMEABILITY; CELL ADHESION; CELL ADHESION MOLECULES; CELLS, CULTURED; COCULTURE TECHNIQUES; DIABETIC ANGIOPATHIES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EMODIN; ENDOTHELIAL CELLS; GLUCOSE; GLUCOSIDES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; NF-KAPPA B; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; VASCULITIS;

EID: 84896353574     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9741-9     Document Type: Article

References (31)

1. Kannel, W.B.; and D.L. McGee. 1979. Diabetes and cardiovascular disease. The Framingham study. JAMA 241: 2035-2038.
2. Kannel, W.B.; and D.L. McGee. 1979. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 2: 120-126.
3. Chistiakov, D.A. 2011. Diabetic retinopathy: pathogenic mechanisms and current treatments. Diabetes Metabolic Syndrome 5: 165-172.
4. Gerrity, R.G. 1981. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. American Journal of Pathology 103: 181-190.
5. Wardle, E.N. 1994. Vascular permeability in diabetics and implications for therapy. Diabetes Research and Clinical Practice 23: 135-139.
6. Esposito, C.; G. Fasoli, A.R. Plati, et al. 2001. Long-term exposure to high glucose up-regulates VCAM-induced endothelial cell adhesiveness to PBMC. Kidney International 59: 1842-1849.
7. Hamuro, M.; J. Polan, M. Natarajan, and S. Mohan. 2002. High glucose induced nuclear factor kappa B mediated inhibition of endothelial cell migration. Atherosclerosis 162: 277-287.
8. Morigi, M.; S. Angioletti, B. Imberti, et al. 1998. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-κB-dependent fashion. Journal of Clinical Investigation 101: 1905-1915.
9. Tooke, J.E. 1995. Microvascular function in human diabetes. A physiological perspective. Diabetes 44: 721-726.
10. Nannipieri, M.; L. Rizzo, A. Rapuano, A. Pilo, G. Penno, and R. Navalesi. 1995. Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients. Diabetes Care 18: 1-9.
11. Lopes-Virella, M.F.; and G. Virella. 1992. Immune mechanisms of atherosclerosis in diabetes mellitus. Diabetes 41(Suppl 2): 86-91.
12. Bae, J.S. 2012. Role of high mobility group box 1 in inflammatory disease: focus on sepsis. Archives of Pharmacal Research 35: 1511-1523.
13. Kado, S.; T. Wakatsuki, M. Yamamoto, and N. Nagata. 2001. Expression of intercellular adhesion molecule-1 induced by high glucose concentrations in human aortic endothelial cells. Life Sciences 68: 727-737.
14. Aggarwal, B.B.; H. Ichikawa, P. Garodia, et al. 2006. From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opinion on Therapeutic Targets 10: 87-118.
15. Lee, W.; S.K. Ku, T.H. Kim, and J.S. Bae. 2013. Emodin-6-O-beta-d- glucoside inhibits HMGB1-induced inflammatory responses in vitro and in vivo. Food and Chemical Toxicology 52: 97-104.
16. Qureshi, S.H.; C. Manithody, J.S. Bae, L. Yang, and A.R. Rezaie. 2008. Autolysis loop restricts the specificity of activated protein C: analysis by FRET and functional assays. Biophysical Chemistry 134: 239-245.
17. Kim, T.H.; and J.S. Bae. 2010. Ecklonia cava extracts inhibit lipopolysaccharide induced inflammatory responses in human endothelial cells. Food and Chemical Toxicology 48: 1682-1687.
18. Bae, J.S.; W. Lee, and A.R. Rezaie. 2012. Polyphosphate elicits proinflammatory responses that are counteracted by activated protein C in both cellular and animal models. Journal of Thrombosis and Haemostasis.
19. Lee, J.D.; J.E. Huh, G. Jeon, et al. 2009. Flavonol-rich RVHxR from Rhus verniciflua stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models. International Immunopharmacology 9: 268-276.
20. Akeson, A.L.; and C.W. Woods. 1993. A fluorometric assay for the quantitation of cell adherence to endothelial cells. Journal of Immunological Methods 163: 181-185.
21. Kim, I.; S.O. Moon, S.H. Kim, H.J. Kim, Y.S. Koh, and G.Y. Koh. 2001. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. Journal of Biological Chemistry 276: 7614-7620.
22. Mackman, N.; K. Brand, and T.S. Edgington. 1991. Lipopolysaccharide- mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. Journal of Experimental Medicine 174: 1517-1526.
23. Laakso, M. 1999. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48: 937-942.
24. Sander, B.; M. Larsen, C. Engler, H. Lund-Andersen, and H.H. Parving. 1994. Early changes in diabetic retinopathy: capillary loss and blood-retina barrier permeability in relation to metabolic control. Acta Ophthalmologica 72: 553-559.
25. Hansson, G.K.; and P. Libby. 2006. The immune response in atherosclerosis: a double-edged sword. Nature Reviews Immunology 6: 508-519.
26. Boisvert, W.A. 2004. Modulation of atherogenesis by chemokines. Trends in Cardiovascular Medicine 14: 161-165.
27. Inoguchi, T.; P. Li, F. Umeda, et al. 2000. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939-1945.
28. Dunlop, M. 2000. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney International. Supplement 77: S3-S12.
29. Han, H.J.; Y.J. Lee, S.H. Park, J.H. Lee, and M. Taub. 2005. High glucose-induced oxidative stress inhibits Na+/glucose cotransporter activity in renal proximal tubule cells. American Journal of Physiology. Renal Physiology 288: F988-F996.
30. Rimbach, G.; G. Valacchi, R. Canali, and F. Virgili. 2000. Macrophages stimulated with IFN-gamma activate NF-kappa B and induce MCP-1 gene expression in primary human endothelial cells. Molecular Cell Biology Research Communications 3: 238-242.
31. Uemura, S.; H. Matsushita, W. Li, et al. 2001. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circulation Research 88: 1291-1298.